Liver Transplantation
📧 Sign up to get email alerts when something new happens for Liver Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India [Phase 4]
A Phase 4 clinical trial evaluating Advagraf (tacrolimus) for safety and efficacy in kidney and liver transplant recipients in India has com…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection [Phase 2]
Phase 2 trial evaluating thymoglobulin induction with reduced doses of calcineurin inhibitors in liver transplant recipients to prevent reje…
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX [Phase 2]
Phase 2 liver transplantation trial comparing sequential therapy with tacrolimus plus an anti-IL-2 receptor monoclonal antibody and mycophen…
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: The Effects of Glucose/Ischemic Preconditioning on Reperfusion Injury in Deceased-Donor Liver Transplantation [Phase 3]
Phase 3 clinical trial evaluating glucose/ischemic preconditioning to reduce reperfusion injury in deceased-donor liver transplantation; the…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients. [Phase 4]
Phase 4 clinical trial evaluating CellCept (mycophenolate mofetil) in combination therapy for liver transplant patients has completed, with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: Vecuronium Requirements According to the Operation Phase During Liver Transplantation Under Desflurane Anesthesia
This completed clinical trial evaluated how vecuronium requirements change during different phases of liver transplantation performed under …
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Early Rehabilitation Program is Feasible and Safe in ICU in Liver Transplanted Patients [NA]
A clinical trial update reports that an early rehabilitation program in the ICU for liver transplant recipients is feasible and safe.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients [Phase 2]
A Phase 2 study evaluating the pharmacokinetics of a modified-release tacrolimus–based immunosuppression regimen in stable liver transplant …
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival
This completed clinical trial from NIAID examined how donor and recipient genetic expression influences survival after heart, lung, liver, a…
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance [Phase 1]
Phase 1 clinical trial investigating whether human mesenchymal stem cells can induce tolerance in liver transplant recipients.
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients [Phase 3]
A Phase 3 trial evaluating concentration-controlled everolimus to eliminate or reduce tacrolimus compared with tacrolimus alone in de novo l…
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Effect of Rapid Transfusion With Fluid Management System 2000® (FMS) [NA]
A completed clinical trial evaluating rapid transfusion with the Fluid Management System 2000 (FMS) in liver transplantation.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients [Phase 2]
Phase 2 trial evaluating tacrolimus-based immunosuppression with steroids versus a monoclonal anti-IL2R antibody in hepatitis C–positive liv…
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Steroid Free Immunosuppression in Liver Transplantation [Phase 4]
Phase 4 clinical trial update showing results of a steroid-free immunosuppression strategy in liver transplantation; the study is completed …
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Belatacept in Liver Transplant Recipients [Phase 2]
A Phase 2 trial of belatacept for immunosuppression in liver transplant recipients was terminated; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: Albumin, Total and Free Fraction of Mycophenolic Acid, and Measurement of IMPDH Activity in Liver Transplants.
This completed liver transplant pharmacokinetic/pharmacodynamic study evaluated albumin binding of mycophenolic acid (total and free fractio…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients
This completed clinical trial evaluated management of heparin-induced thrombocytopenia in liver transplant recipients.
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients [Phase 2]
A National Institute of Allergy and Infectious Diseases–sponsored Phase 2 trial evaluated immune suppression using alemtuzumab and tacrolimu…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation [Phase 2]
A randomized Phase II trial evaluating Civacir (hepatitis C immune globulin intravenous) in liver transplant recipients was terminated; resu…
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant [Phase 4]
Phase 4 clinical trial evaluating whether angiotensin II receptor blockade affects kidney function and scarring after liver transplantation.…
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids [Phase 3]
A Phase 3 trial in pediatric de novo liver transplant recipients evaluated basiliximab in combination with cyclosporine (including cyclospor…
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients [Phase 1]
Phase 1 trial update on withdrawing immunosuppression in pediatric liver transplant recipients has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-04-07Clinical Trial Update: RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency [Phase 3]
The RESCUE Phase 3 trial evaluated Everolimus in liver transplant recipients with renal insufficiency. The study is completed and results we…
-
CLINICAL_TRIALS trial_result · 2011-03-03Clinical Trial Update: Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion Protocols
A completed clinical trial comparing depletion versus non-depletion immunosuppressive protocols in solid organ transplant recipients, examin…
-
CLINICAL_TRIALS trial_result · 2011-03-03Clinical Trial Update: Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients [Phase 3]
Phase 3 clinical trial update evaluating gastrointestinal and health-related quality of life outcomes in liver transplant recipients; result…